EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients

Sena Ikemoto, Fuminori Sakurai iD, Sora Tokuoka, Tomoki Yamashita, Kosuke Takayama, Kazuaki Hoshi, Takahiro Okabe, Issei Sumiyoshi, Shinsaku Togo, Kazuhisa Takahashi, Masashi Tachibana, Hiroyuki Mizuguchi

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sena Ikemoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science London, Japan Research Foundation for Clinical Pharmacology, Oncolys BioPharma Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) are present in the blood of cancer patients from the early stage of cancer development, and their presence has been correlated with patient prognosis and treatment responses. Accordingly, CTCs have been attracting attention as a novel biomarker for early detection of cancer and monitoring of treatment responses. However, since patients typically have only a few CTCs per milliliter of blood, development of an accurate and highly sensitive CTC detection method is crucial. We previously developed a CTC detection method using a novel conditionally replicating adenovirus (Ad) that expresses green fluorescence protein (GFP) in a tumor cell-specific manner by expressing the E1 gene using a tumor-specific human telomerase reverse transcriptase (hTERT) promoter (rAdF35-142T-GFP). CTCs were efficiently detected using rAdF35-142T-GFP, but GFP expression levels in the CTCs and production efficiencies of rAdF35-142T-GFP were relatively low. In this study, in order to overcome these problems, we developed four types of novel GFP-expressing conditionally replicating Ads and examined their ability to visualize CTCs in the blood samples of lung cancer patients. Among the four types of novel recombinant Ads, the novel conditionally replicating Ad containing the 2A peptide and the GFP gene downstream of the E1A gene and the adenovirus death protein (ADP) gene in the E3 region (rAdF35-E1-2A-GFP-ADP) mediated the highest number of GFP-positive cells in the human cultured tumor cell lines. Titers of rAdF35-E1-2A-GFP-ADP were significantly higher (about 4-fold) than those of rAdF35-142T-GFP. rAdF35-E1-2A-GFP-ADP and rAdF35-142T-GFP efficiently detected CTCs in the blood of lung cancer patients at similar levels. GFP+/CD45- cells (CTCs) were found in 10 of 17 patients (58.8%) for both types of recombinant Ads.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingLung NeoplasmsHumansAdenoviridaeGreen Fluorescent ProteinsTumor Cells, CulturedCell Line, Tumor

Substanzen

Green Fluorescent Proteins

Autor:innen und Institutionen

  • Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Department of Minimally Invasive Next-generation Cancer Diagnosis by TelomeScan, Tokyo, Japan.
  • Leading Center for the Development and Research of Cancer Medicine, Juntendo University, Tokyo, Japan.
  • Division of Respiratory Medicine, Juntendo University Faculty of Medicine & Graduate School of Medicine, Tokyo, Japan.
  • The Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka, Japan.
  • Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan.

ORCID-Profile: Fuminori Sakurai

Förderung

  • Japan Society for the Promotion of Science London
  • Japan Research Foundation for Clinical Pharmacology
  • Oncolys BioPharma Inc

Zitieren

APA

Ikemoto, S., Sakurai, F., Tokuoka, S., Yamashita, T., Takayama, K., Hoshi, K., Okabe, T., Sumiyoshi, I., Togo, S., Takahashi, K., Tachibana, M., & Mizuguchi, H. (2023). Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0286323

Vancouver

Ikemoto S, Sakurai F, Tokuoka S, Yamashita T, Takayama K, Hoshi K, et al. Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients. PLOS ONE. 2023. doi:10.1371/journal.pone.0286323

BibTeX
@article{Ikemoto2023,
  author = {Ikemoto, Sena and Sakurai, Fuminori and Tokuoka, Sora and Yamashita, Tomoki and Takayama, Kosuke and Hoshi, Kazuaki and Okabe, Takahiro and Sumiyoshi, Issei and Togo, Shinsaku and Takahashi, Kazuhisa and Tachibana, Masashi and Mizuguchi, Hiroyuki},
  title = {Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286323}
}
Kostenlos starten →